Design Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 265.5% | 3,422.6% | 9,570.0% | 8,206.1% | – | – | – | – | – | – | – | – | – | – | – | 16.5% | – | – | – | 25.3% | – | – | – | – | – | – | – | |
| -165.5% | -3,322.6% | -9,470.0% | -8,106.1% | – | – | – | – | – | – | – | – | – | – | – | -16.5% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| 265.5% | 3,422.6% | 9,570.0% | 8,206.1% | – | – | – | – | – | – | – | – | – | – | – | 1,314.1% | – | – | – | 2,067.5% | – | – | – | – | – | – | – | |
| 273.2% | 1,396.8% | 2,445.0% | 3,593.9% | – | – | – | – | – | – | – | – | – | – | – | 490.3% | – | – | – | 771.6% | – | – | – | – | – | – | – | |
| 438.7% | 4,719.4% | 11,915.0% | 11,700.0% | – | – | – | – | – | – | – | – | – | – | – | 1,804.4% | – | – | – | 2,839.1% | – | – | – | – | – | – | – | |
| -438.7% | -4,719.4% | -11,915.0% | -11,700.0% | – | – | – | – | – | – | – | – | – | – | – | -1,804.4% | – | – | – | -2,839.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 15.4% | – | – | – | – | – | – | – | – | – | – | – | |
| -466.9% | -4,651.6% | -11,600.0% | -11,681.8% | – | – | – | – | – | – | – | – | – | – | – | -1,413.1% | – | – | – | -2,321.6% | – | – | – | – | – | – | – | |
| -438.7% | -4,719.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | 297.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -466.9% | -4,651.6% | -11,600.0% | -11,681.8% | – | – | – | – | – | – | – | – | – | – | – | -1,413.1% | – | – | – | -2,321.6% | – | – | – | – | – | – | – | |
| -438.7% | -4,719.4% | -11,910.0% | -11,687.9% | – | – | – | – | – | – | – | – | – | – | – | -1,396.7% | – | – | – | -2,296.3% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.